AES-350 is a potent and orally active HDAC6 inhibitor with an IC50 and a Ki of 0.0244 µM and 0.035 µM, respectively. AES-350 is also against HDAC3, HDAC8 in an enzymatic activity assay with IC50 values of 0.187 µM and 0.245 µM, respectively. AES-350 triggers apoptosis in AML cells through HDAC inhibition and can be used for acute myeloid leukemia (AML) research[1].
Molekulargewicht:
312.36
Reinheit:
99.30
CAS Nummer:
[847249-57-4]
Formel:
C18H20N2O3
Target-Kategorie:
Apoptosis,HDAC
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten